Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To investigate safety of treatment with allogeneic adipose tissue-derived mesenchymal stromal cells (ASCs) in patients undergoing lung transplantation, to evaluate whether the treatment can reduce host immunological reaction towards the graft, and to reduce the ischemic reperfusion-injury after transplantation.
Epistemonikos ID: e6e4050ad17b01440b0c83e5a1c9b0273637c24b
First added on: May 08, 2024